Trusted Resource for Clinical Trials, Protocols & Progress
The clinical research industry is undergoing a digital transformation fueled by blockchain, AI, remote monitoring, and decentralized trials. In parallel, data protection laws are expanding globally—demanding that sponsors and CROs not only comply with existing frameworks like GDPR and HIPAA, but also anticipate how these laws will evolve by 2030.
Click to read the full article.
A Data Protection Impact Assessment (DPIA) is a mandatory tool under the General Data Protection Regulation (GDPR) when processing activities are likely to result in high risk to individuals’ rights and freedoms. For clinical trials, this includes the use of:
Click to read the full article.
Informed consent is not just a signature—it is an ongoing process of ensuring patients understand their role in a clinical trial, the use of their personal data, and their right to withdraw at any time. Regulatory frameworks such as GCP, GDPR, and HIPAA all emphasize different facets of subject rights, and sponsors/CROs must integrate these into their consent workflows.
Click to read the full article.
Data flow mapping is a visual and documented representation of how personal and clinical trial data moves through various systems, vendors, and geographies. Regulatory authorities like the EMA and FDA now expect sponsors and CROs to maintain detailed flowcharts showing:
Click to read the full article.
A data breach is defined as any unauthorized access, disclosure, alteration, or loss of personal data. In clinical research, this often involves subject data collected via electronic systems such as:
Click to read the full article.
A Data Protection Impact Assessment (DPIA) is a structured process used to evaluate potential privacy risks when handling personal data in a clinical trial. Under the EU GDPR Article 35, a DPIA is required when a study:
Click to read the full article.
Data localization refers to the legal requirement to store or process data within the borders of the country where it was collected. In clinical trials, localization mandates impact trial master file (TMF) hosting, EDC servers, patient registries, and pharmacovigilance databases. Authorities across the globe have enacted data residency rules to ensure:
Click to read the full article.
The Health Insurance Portability and Accountability Act (HIPAA) is a U.S. federal law enacted in 1996 that protects individuals’ medical records and other personal health information (PHI). For U.S.-based clinical trials involving protected health information (PHI or ePHI), HIPAA compliance is non-negotiable. HIPAA applies when:
Click to read the full article.
The General Data Protection Regulation (GDPR) is the cornerstone of data privacy legislation in the European Union. Any clinical trial that processes data from EU residents, regardless of where the sponsor, CRO, or site is located, must comply with GDPR. The regulation introduces strict requirements for:
Click to read the full article.
